TTrialPathMatch Me to Trials
← Back to trials
RecruitingSpinal Column Tumor

Primary Tumor Research and Outcomes Network

Eligible age

All ages

Accepts

All genders

Locations

7 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This project aims to establish a network of spine oncology centers dedicated to prospective multicenter research of patients diagnosed with a primary tumor of the spine and will include a comprehensive prospective clinical database which will serve as a shared research platform. Demographic, clinical, diagnostic, and therapeutic variables will be used to answer questions about survival and local recurrence, as well as questions about adverse events (AEs), morbidity data, and health-related quality of life (HRQOL) outcomes.

Sponsor: AO Innovation Translation Center

You may qualify if…

  • Patient with a current primary spine tumor or history of a primary spine tumor, including tumors within or surrounding the spinal column and/or spinal cord. This includes extradural tumors, intramedullary tumors (i.e. astrocytomas, ependymoma, etc.) and extramedullary tumors (i.e. meningiomas, neurofibromas, schwannomas, etc.).
  • Informed consent obtained, i.e.:
  • Ability to understand the content of the patient information/ICF
  • Willingness and ability to participate in the registry according to the Registry Plan (RP)
  • Signed and dated EC/IRB approved written informed consent
  • OR
  • Written consent provided according to the IRB/EC defined and approved procedures for patients who are not able to provide independent written informed consent

You may not qualify if…

  • \- Patient diagnosed with a metastatic tumor of the spine.

Where it's recruiting

California

Los Angeles · San Francisco

Maryland

Baltimore

Minnesota

Rochester

New York

New York

Rhode Island

Providence

Texas

Houston

Source: ClinicalTrials.gov · NCT02790983 · last updated 2026-02-25

Primary Tumor Research and Outcomes Network · TrialPath